
Sign up to save your podcasts
Or


Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
By JAMA Network4.3
106106 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

498 Listeners

162 Listeners

8,857 Listeners

111,848 Listeners

38 Listeners

21 Listeners

12 Listeners

11 Listeners

9 Listeners

16 Listeners

19 Listeners

5 Listeners

7 Listeners

30 Listeners

9 Listeners

94 Listeners

14 Listeners

5 Listeners

5 Listeners

367 Listeners

5,802 Listeners

18 Listeners

3 Listeners